EC-5000 EXCIMER LASER SYSTEM

Excimer Laser System

FDA Premarket Approval P970053

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the nidek ec-5000 excimer laser system. This device is indicated for photorefractive keratectomy (prk) for the reduction or elimination of mild to moderate myopia in patients with the following three characterisitics: 1) in prk treatments for the reduction or elimination of myopia in the low, moderate, or high ranges (-0. 75 diopters (d) to -13. 00d) spherical equivalent (s. E. ) at the spectacle plan, uncomplicated by refractive astigmatism (i. E. ,

DeviceEC-5000 EXCIMER LASER SYSTEM
Classification NameExcimer Laser System
Generic NameExcimer Laser System
ApplicantNIDEK CO., LTD.
Date Received1997-11-06
Decision Date1998-12-17
Notice Date2000-12-08
PMAP970053
SupplementS
Product CodeLZS
Docket Number00M-1640
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address NIDEK CO., LTD. 34-14 Maehama, Hiroishi-cho gamagori, Aichi 443-0-0038
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P970053Original Filing
S017 2017-07-17 Normal 180 Day Track
S016 2017-03-13 Real-time Process
S015 2014-10-03 Normal 180 Day Track
S014 2014-08-18 Real-time Process
S013 2014-02-11 Normal 180 Day Track
S012 2012-09-25 Normal 180 Day Track
S011 2007-03-30 Panel Track
S010 2006-08-08 Normal 180 Day Track
S009 2005-11-23 Panel Track
S008 2004-04-19 Real-time Process
S007 2002-05-23 Normal 180 Day Track
S006 2001-03-15 Normal 180 Day Track
S005 2001-01-30 Normal 180 Day Track
S004
S003 2000-04-28 Normal 180 Day Track
S002 1999-04-19 Panel Track
S001 1999-02-16 Panel Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.